IP Library Granted Patent US 7,595,038
Granted Patent B2
US 7,595,038 · App. 11/738,846 · Granted Sep 29, 2009

Methods of treatment using antibodies to follistatin-3

Assignee: Human Genome Sciences, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,595,038
App. No.
11/738,846
Granted
Sep 29, 2009
Kind
B2
Abstract

The present invention relates to a novel follistatin-3 protein which is a member of the family of inhibin-related proteins. In particular, isolated nucleic acid molecules are provided encoding the human follistatin-3 protein. Follistatin-3 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of follistatin-3 activity. Also provided are diagnostic methods for detecting reproductive system-related disorders and disorders of the regulation of cell growth and differentiation and therapeutic methods for treating reproductive system-related disorders and disorders of the regulation of cell growth and differentiation.

Claims (6)

1. A method of inhibiting the proliferation of immune cells in leukemia comprising administering to an individual an effective amount of an antibody that specifically binds a follistatin-3 polypeptide having an amino acid sequence consisting of amino acid residues 1 to 237 of SEQ ID NO:2, wherein either B cell or T cell proliferation is inhibited.

2. The method of claim 1 , wherein the antibody inhibits Follistatin-3 binding to the Activin A protein.

3. The method of claim 1 , wherein the antibody inhibits Follistatin-3 binding to the Activin B protein.

4. The method of claim 1 wherein B cell proliferation is inhibited.

5. The method of claim 1 wherein T cell proliferation is inhibited.

6. The method of claim 1 wherein said antibody inhibits the survival of immune cells.

Continuity (9)
Division 1115511400 · Jun 17, 2005
Division 1037287400 · Feb 26, 2003
Division 0961780400 · Jul 14, 2000
Continuation In Part 0914102700 · Aug 27, 1998
Continuation In Part 1010139200 · Mar 20, 2002
Division 0914102700 · Aug 27, 1998
Provisional Application 6005624800 · Aug 29, 1997
Provisional Application 6014408800 · Jul 16, 1999
Related Publication 20070275895A1 · Nov 29, 2007